Yunnan Botanee Bio-Technology Group Co

Yunnan Botanee Bio-Technology Group Co EBIT per Employee

The EBIT per Employee of Yunnan Botanee Bio-Technology Group Co (300957.SZ) as of Nov 1, 2026 is 204,734.86 CNY. In the previous year, EBIT per Employee was 204,558.73 CNY — a change of 0.09% (higher).

EBIT per Employee

204,734.86CNY

YoY

0.09%

Last updated:

EBIT per Employee of Yunnan Botanee Bio-Technology Group Co is 2025 204,734.86 CNY. EBIT per Employee of Yunnan Botanee Bio-Technology Group Co was 2024 204,558.73 CNY. It decreases by 0.09% higher compared to the previous year.

The Yunnan Botanee Bio-Technology Group Co EBIT per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Employee
Date
EBIT per Employee
Jan 1, 2018
102,414.97 CNY
Jan 1, 2019
164,453.62 CNY
Jan 1, 2020
212,807.48 CNY
Jan 1, 2021
332,692.37 CNY
Jan 1, 2022
397,022.27 CNY
Jan 1, 2023
287,577.37 CNY
Jan 1, 2024
204,558.73 CNY
Jan 1, 2025
204,734.86 CNY
The Yunnan Botanee Bio-Technology Group Co EBIT per Employee history
YEAREBIT per EmployeeYoY
204,734.86CNY+0.09%
204,558.73CNY-28.87%
287,577.37CNY-27.57%
397,022.27CNY+19.34%
332,692.37CNY+56.33%
212,807.48CNY+29.40%
164,453.62CNY+60.58%
102,414.97CNY+68.02%
60,952.30CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Yunnan Botanee Bio-Technology Group Co Stock analysis

What does Yunnan Botanee Bio-Technology Group Co do? Yunnan Botanee Bio-Technology Group Co., Ltd. generates revenue through the research, development, manufacture, and sales of skin care products and services. The company's product portfolio includes creams, skin care lotions, facial masks, essences, lotions, and makeup items such as isolation creams, blemish balm (BB) creams, and makeup removers. Additionally, it offers medical device products like hyaluronic acid repairing biofilm and hyaluronic acid repairing dressings, designed for skin barrier protection post-minimally invasive surgery. Sales are driven by both offline and online channels, with the firm focusing on these distribution methods as key revenue streams. The company targets consumers seeking skincare solutions, particularly those requiring post-surgical skin care, through its medical device line. Its product range caters to a broad market segment, including daily skincare users and individuals needing specialized care for skin conditions. The firm's emphasis on both conventional skincare and medical-grade products allows it to address diverse consumer needs across multiple segments. Yunnan Botanee's revenue model relies on direct sales of its skincare and medical device products, with no mention of external partnerships or third-party branding. The company's focus on in-house R&D and manufacturing ensures control over product quality and pricing, supporting consistent revenue generation from its established customer base. Yunnan Botanee Bio-Technology Group Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Yunnan Botanee Bio-Technology Group Co stock

EBIT per Employee of Yunnan Botanee Bio-Technology Group Co is 204,734.86 CNY in 2025.

EBIT per Employee of Yunnan Botanee Bio-Technology Group Co changed from 204,558.73 CNY to 204,734.86 CNY, representing a 0.09% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Employee Yunnan Botanee Bio-Technology Group Co since 2006 – with annual values, charts, and detailed analysis.

EBIT per employee measures operating profit per employee, showing how efficiently the workforce generates operating earnings.

EBIT per Employee's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT per Employee's Yunnan Botanee Bio-Technology Group Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Yunnan Botanee Bio-Technology Group Co

All Key Metrics — Yunnan Botanee Bio-Technology Group Co